Pharmafile
Is the Current EU Legal Framework for Orphan Medicines Fit for Purpose?
Autumn 2019
Maria Isabel Manley, partner and head of the UK Global Life Sciences Practice, and Chris Boyle, associate, at Sidley, discuss the impact of regulatory frameworks on medicines for rare diseases.
Contacts
Capabilities
Suggested News & Insights
2026 Momentum Food and Beverage ExchangeOctober 6-7, 2026Sidley Represents Rael in Its Strategic Investment from TowerBrook Capital PartnersAugust 24, 2026Sidley Represents Werewolf Therapeutics in Merger with Ambros Therapeutics and Concurrent US$150 Million Private PlacementAugust 21, 2026Through the Looking Glass: What WHA79 Reveals About the Future of Global Life SciencesAugust 2026Switzerland Expands Integrity Rules to Medical Devices: Key Compliance Implications for Medtech CompaniesAugust 2026Shifting Expectations: FDA Takes a First Step Toward Making GRAS Notifications MandatoryAugust 12, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory